Trial
NCT00712426
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Massachusetts General Hospital
Collaborators
University of Rochester; National Center for Complementary and Integrative Health (NCCIH)
Condition
Huntington's Disease
Intervention
Creatine Monohydrate
Why stopped
Results of an interim analysis showed that it was unlikely that creatine was effective in slowing loss of function in early symptomatic Huntington's Disease.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-11